| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336297A2 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/22/2011 | EP2336169A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
| 06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
| 06/22/2011 | EP2336145A1 Antisense modulation of apolipoprotein B expression |
| 06/22/2011 | EP2336111A1 Heterocyclic inhibitors of p38 |
| 06/22/2011 | EP2335726A1 Fusion molecules and methods for treatment of immune diseases |
| 06/22/2011 | EP2335719A1 Use of hemojuvelin fusion proteins to regulate hepcidin-mediated iron metabolism |
| 06/22/2011 | EP2335709A1 Insulin resistance improving agent |
| 06/22/2011 | EP2335494A1 Method for concentrating lipid |
| 06/22/2011 | EP2334687A1 Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives |
| 06/22/2011 | EP2334684A1 Pyrazolopyrimidines and their use for the treatment of cns disorders |
| 06/22/2011 | EP2334666A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/22/2011 | EP2334659A2 Phenyl malonic acid derivatives |
| 06/22/2011 | EP2334377A1 Herbal extract as sensitivity enhancer toward insulin and antidiabetes |
| 06/22/2011 | EP2334295A1 Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same |
| 06/22/2011 | EP2334292A1 Method of determining a phosphorus binder dosage for a dialysis patient |
| 06/22/2011 | EP2334181A1 Phthalimide derivative metabotropic glutamate r4 ligands |
| 06/22/2011 | EP2252591B1 Aryl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 06/22/2011 | EP2203448B1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical |
| 06/22/2011 | EP2094254B1 Treatment of cachexia |
| 06/22/2011 | EP1616856B1 Novel transcriptional factor, process for producing the same and use thereof |
| 06/22/2011 | EP1341526B1 Pharmaceutical compositions for the oral delivery of calcitonin |
| 06/22/2011 | EP1324771B1 Therapeutic and tolerance inducing antibodies |
| 06/22/2011 | CN1903364B Medicine composition containing inhibitor of angiotonase and phenoxy acid compounds |
| 06/22/2011 | CN1883537B Compound Chinese medicinal preparation for treating hypertension and hyperlipemia and preparation method thereof |
| 06/22/2011 | CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 06/22/2011 | CN102105789A Brown adipocyte progenitors in human skeletal muscle |
| 06/22/2011 | CN102105452A Substituted carbinol compound having cyclic linker |
| 06/22/2011 | CN102105451A Glucokinase activators |
| 06/22/2011 | CN102105171A Modified release niacin formulations |
| 06/22/2011 | CN102105145A Treatment for diabetes in patients inappropriate for metformin therapy |
| 06/22/2011 | CN102102060A Production process for red-rooted salvia root yellow wine |
| 06/22/2011 | CN102101825A PTP1B (Protein Tyrosine Phosphatase 1B) inhibitor, and synthesis and application thereof |
| 06/22/2011 | CN102101661A Method for preparing high-purity monopotassium phosphate crude medicine |
| 06/22/2011 | CN102100907A Composition of oral pharmacologic active agent |
| 06/22/2011 | CN102100906A Medicinal preparation of exenatide and preparation method thereof |
| 06/22/2011 | CN102100904A Reduced glutathione percutaneous absorption preparation and preparation method thereof |
| 06/22/2011 | CN102100889A Preparation technology of new integrative formulation of spleen-returning decoction |
| 06/22/2011 | CN102100875A Process method for microwave assistant supercritical extraction of active ingredients of curcuma |
| 06/22/2011 | CN102100874A Chinese patent drug for treating diabetes and preparation method thereof |
| 06/22/2011 | CN102100858A Chinese medicinal preparation for treating early diabetic nephropathy and preparation method thereof |
| 06/22/2011 | CN102100844A Nano traditional Chinese medicine used for treating diabetes and production method thereof |
| 06/22/2011 | CN102100834A Chinese medicine composition for treating diabetic nephropathy (DN) as well as preparation and preparation method thereof |
| 06/22/2011 | CN102100828A Medicament for treating diabetes mellitus |
| 06/22/2011 | CN102100820A Soup capable of dissolving phlegm and tonifying spleen |
| 06/22/2011 | CN102100813A Preparation technology of new integrative formulation of poria five powder and production method thereof |
| 06/22/2011 | CN102100770A Traditional Chinese medicine preparation for treating hyperlipidemia |
| 06/22/2011 | CN102100761A Plant extract composition for preventing and treating lipidmetabolic disorder and preparation method thereof |
| 06/22/2011 | CN102100760A Plant extract composition capable of preventing and treating sugar metabolism disturbance and preparation method thereof |
| 06/22/2011 | CN102100742A Water-solubility extract of root of red-rooted salvia, preparation method thereof and application thereof |
| 06/22/2011 | CN102100685A PTP1B inhibitor and synthetic method and application thereof |
| 06/22/2011 | CN101732491B Medicament for treating hypertension, hyperlipoidemia, high blood viscosity and anti-aging |
| 06/22/2011 | CN101708301B Medicament for treating noninsulin-dependent and insulin-dependent diabetes mellitus |
| 06/22/2011 | CN101693068B Medicament for lowering blood pressure and blood lipid |
| 06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/22/2011 | CN101570512B Curcumin substituted pyrazole derivatives, and preparation method and uses thereof |
| 06/22/2011 | CN101538293B Method for preparing secoisolariciresinol diglucoside and ferulic acid glucoside or ferulic acid glucoside ethyl ester |
| 06/22/2011 | CN101475615B Amino acid glucide compound and its use |
| 06/22/2011 | CN101365432B Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 06/22/2011 | CN101352512B Chinese medicine composition for treating diabetes and method for preparing the same |
| 06/22/2011 | CN101264316B Preparation of medicinal protolysate |
| 06/22/2011 | CN101234136B Medicament for curing diabetes retina affection |
| 06/22/2011 | CN101152395B Chinese medicine for treating diabetes |
| 06/22/2011 | CN101084885B Two sustained-release preparations containing cinnamic acid for preventing coxsackie virus and preparation technology thereof |
| 06/22/2011 | CN101020047B Health food containing calcium reinforcing agent |
| 06/22/2011 | CN101002825B Method for preparing Duzhong soft capsule rich in alpha-linolenic acid and effective component of bark of eucommia |
| 06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964581 Use of difructose anhydride-containing composition |
| 06/21/2011 | US7964564 Chimeric natriuretic peptides |
| 06/21/2011 | US7964216 Orally administering to a patient a spaced drug delivery system, wherein first therapeutically active agent is released immediately and second therapeutically active agent is released as a pulse at predetermined time after administration |
| 06/21/2011 | US7964183 Composition and dosage form comprising a particle formulation and suspending vehicle |
| 06/21/2011 | CA2649403C Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 06/21/2011 | CA2646962C Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 06/21/2011 | CA2641379C Heterobicyclic sulfonamide derivatives for the treatment of diabetes |
| 06/21/2011 | CA2633440C 1,3-dioxane carboxylic acids |
| 06/21/2011 | CA2611086C Agent for inhibiting visceral fat accumulation |
| 06/21/2011 | CA2563000C Indene derivatives and process for the preparation thereof |
| 06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/21/2011 | CA2462537C Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 06/21/2011 | CA2431011C Compositions and methods of use for extracts of magnoliaceae plants |
| 06/21/2011 | CA2396785C A medicinal aerosol formulation |
| 06/21/2011 | CA2396648C A medicinal aerosol formulation |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/16/2011 | WO2011072288A2 Insulin analogues with chlorinated amino acids |
| 06/16/2011 | WO2011072263A1 Pcsk9 antagonists |
| 06/16/2011 | WO2011071916A2 Sr-bi as a predictor of human female infertility and responsiveness to treatment |
| 06/16/2011 | WO2011071840A1 Inhibitors of diacylglycerol acyltransferase |
| 06/16/2011 | WO2011071783A1 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof |
| 06/16/2011 | WO2011071684A1 Oral rehydration solutions comprising dextrose |
| 06/16/2011 | WO2011071565A1 Tgr5 agonists |
| 06/16/2011 | WO2011071371A1 Metabolic imprinting effects of structured lipids |
| 06/16/2011 | WO2011071367A1 Metabolic imprinting effects of structured lipids |